CLINICAL_TRIALS
trial_result
· 2018-06-21
Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Chronic Migraine Prevention [Phase 2]
Summary
Phase 2 clinical trial update evaluating the efficacy and safety of erenumab (AMG 334) for prevention of chronic migraine has completed with results posted in 2…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amgen | Conditions: Treatment for Prevention of Chronic Migraine | Phase 2 | Status: COMPLETED | Results posted: 2018-06-21